Uniwersyteckie Centrum Kliniczne

Warsaw 02-097

1 studies enrolling now · 3 studies all time

What they study most

Heart Failure, Iron-deficiency, Ischemic Stroke; Ischemic Attack, Transient, Multiple Myeloma

Studies at this site

• A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed